Compare SEER & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEER | CSBR |
|---|---|---|
| Founded | 2017 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.3M | 83.5M |
| IPO Year | 2020 | 2015 |
| Metric | SEER | CSBR |
|---|---|---|
| Price | $1.78 | $6.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 364.2K | 6.1K |
| Earning Date | 05-13-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.40 | ★ 161.11 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,578,000.00 | $2,900,000.00 |
| Revenue This Year | $2.14 | $4.84 |
| Revenue Next Year | $25.90 | $11.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 16.99 | N/A |
| 52 Week Low | $1.65 | $5.50 |
| 52 Week High | $2.41 | $9.63 |
| Indicator | SEER | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | 44.80 |
| Support Level | $1.76 | $5.60 |
| Resistance Level | $1.84 | $6.31 |
| Average True Range (ATR) | 0.07 | 0.25 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 32.26 | 14.27 |
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.